Records containing: Previously Treated Childhood Rhabdomyosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-10Cardiac-Sparing Whole Lung IMRT in Children and Young Adults With Lung Metastases: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2023-10-03A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
-
CLINICAL_TRIALS study record update · 2018-08-07A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-06-05A Phase II Study of MLN8237, a Selective Aurora A Kinase Inhibitor in Children With Recurrent/Refractory Solid Tumors and Leukemias
-
CLINICAL_TRIALS study record update · 2017-05-09A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-05-05A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With Intravenous Vinorelbine and Cyclophosphamide in Patients With Recurrent/Refractory Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2017-01-20A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)
-
CLINICAL_TRIALS study record update · 2016-07-14Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2016-05-18Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas
-
CLINICAL_TRIALS study record update · 2016-05-18Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2016-05-17A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2015-05-15A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2015-03-31A Phase II Study of Cixutumumab (IMC-A12) in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-03-30A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, NSC #742460) in Children With Relapsed/Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-11-14Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-14Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-01-27A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2013-06-14Phase II Trial of Irinotecan in Children With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase I Study of Single Agent OSI-774 (Tarceva) (NSC# 718781, IND# 63383) Followed by OSI-774 With Temozolomide for Patients With Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors
-
CLINICAL_TRIALS study record update · 2013-06-04A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-17A Groupwide Randomized Phase II Window Study of Two Different Schedules of Irinotecan in Combination With Vincristine And Pilot Assessment of Safety and Efficacy of Tirapazamine Combined With Multiagent Chemotherapy for First Relapse or Progressive Disease in Rhabdomyosarcoma and Related Tumors